Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroaki Masuzaki

Showing results (1-10 of 221) with videos related to

Pageof 23
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 20, 2011
[Intracellular glucocorticoid reactivating enzyme, 11beta-HSD1 as a therapeutic target of obesity-diabetes syndrome]Hiroaki Masuzaki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 29, 2011
[108th Scientific Meeting of the Japanese Society of Internal Medicine: educational lecture: 9. A novel, interdisciplinary approach toward the rapid expansion of obesity and metabolic syndrome in Japan]Hiroaki Masuzaki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 21, 2005
[Metabolic syndrome and an intra-cellular glucocorticoid activating enzyme, 11 beta-HSD1]Hiroaki Masuzaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 20, 2011
[Increased activity of intracellular glucocorticoid reactivating enzyme, 11beta-HSD1 in obese adipose tissue]Hiroaki Masuzaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 23, 2005
[Obesity and the metabolic syndrome]Hiroaki Masuzaki, Kazuwa Nakao
Frontiers in Molecular Neuroscience|December 11, 2025
Editorial: Nutrient signaling and neuroendocrine pathways in brain-organ communicationHiroyuki Aizawa, Hiroaki Masuzaki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 6, 2018
[Programs for Continuing Medical Education 2016: A Session: 4. Obesity Disease and Metabolic Syndrome: Clinical Progress and Future Outlook]Hiroaki Masuzaki, Michio Shimabukuro
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 20, 2003
Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndromeHiroaki Masuzaki, Jeffrey S Flier
The New England Journal of Medicine|August 6, 2004
Long-term leptin-replacement therapy for lipoatrophic diabetesKen Ebihara, Hiroaki Masuzaki, Kazuwa Nakao
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 27, 2007
[Adipocyte dysfunction and insulin resistance]Tomohiro Tanaka, Hiroaki Masuzaki, Kazuwa Nakao
Pageof 23

Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 20, 2011
[Intracellular glucocorticoid reactivating enzyme, 11beta-HSD1 as a therapeutic target of obesity-diabetes syndrome]Hiroaki Masuzaki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 29, 2011
[108th Scientific Meeting of the Japanese Society of Internal Medicine: educational lecture: 9. A novel, interdisciplinary approach toward the rapid expansion of obesity and metabolic syndrome in Japan]Hiroaki Masuzaki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 21, 2005
[Metabolic syndrome and an intra-cellular glucocorticoid activating enzyme, 11 beta-HSD1]Hiroaki Masuzaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 20, 2011
[Increased activity of intracellular glucocorticoid reactivating enzyme, 11beta-HSD1 in obese adipose tissue]Hiroaki Masuzaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 23, 2005
[Obesity and the metabolic syndrome]Hiroaki Masuzaki, Kazuwa Nakao
Frontiers in Molecular Neuroscience|December 11, 2025
Editorial: Nutrient signaling and neuroendocrine pathways in brain-organ communicationHiroyuki Aizawa, Hiroaki Masuzaki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 6, 2018
[Programs for Continuing Medical Education 2016: A Session: 4. Obesity Disease and Metabolic Syndrome: Clinical Progress and Future Outlook]Hiroaki Masuzaki, Michio Shimabukuro
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 20, 2003
Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndromeHiroaki Masuzaki, Jeffrey S Flier
The New England Journal of Medicine|August 6, 2004
Long-term leptin-replacement therapy for lipoatrophic diabetesKen Ebihara, Hiroaki Masuzaki, Kazuwa Nakao
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 27, 2007
[Adipocyte dysfunction and insulin resistance]Tomohiro Tanaka, Hiroaki Masuzaki, Kazuwa Nakao
Pageof 23